INGALLS & SNYDER LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$483
+4.1%
933,0000.0%0.02%
+4.5%
Q2 2023$464
+5.0%
933,000
-4.6%
0.02%
-4.3%
Q1 2023$442
-4.3%
978,000
+15.3%
0.02%
-8.0%
Q4 2022$462
-99.9%
848,0000.0%0.02%
-3.8%
Q3 2022$473,000
+0.9%
848,0000.0%0.03%
+4.0%
Q2 2022$469,000
+5.6%
848,000
-2.3%
0.02%
+25.0%
Q1 2022$444,000
-3.7%
868,000
-1.7%
0.02%
-4.8%
Q4 2021$461,000883,0000.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders